Spina Bifida
103
17
27
55
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Research Maturity
55 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.9%
4 terminated out of 103 trials
93.2%
+6.7% vs benchmark
1%
1 trials in Phase 3/4
13%
7 of 55 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 55 completed trials
Clinical Trials (103)
tSCS in Children With Spina Bifida
Assessing Transition Practices for Children With Disabilities: Pathways to a Successful Adulthood
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD
Evaluating a New Knee-Ankle-Foot Brace to Improve Gait in Children With Movement Disorders
Establishing the Preliminary Utility of a Novel Pediatric Manual Mobile Standing Wheelchair
Spina Bifida Healthcare Navigator Program
In-Utero Endoscopic Correction of Spina Bifida
Bowel Continence Across the Lifespan in People With Spina Bifida
Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction
Fetoscopic Repair of Isolated Fetal Spina Bifida
Anorectal Dysfunction in Patients Suffering From Spina Bifida : From Clinic to Neuro-epithelial Function (ANOSPIN)
Evaluation of the Transitional and Lifelong Care Program
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
Maternal-fetal Immune Responses to Fetal Surgery
Evaluation of muLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up
Psychosocial Teleassistance Programme for Adults With Spina Bifida
Comparing Digitally and Traditionally Made Ankle Foot Orthoses
High Intensity Exercise and Improving Physical Activity Among People With Neurologic Dysfunction
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida